141 related articles for article (PubMed ID: 26973907)
1. Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study.
Bridou M; Aguerre C; Gimenes G; Kubiszewski V; Le Gall A; Potard C; Sorel O; Reveillere C
Health Psychol Res; 2013 Apr; 1(2):e22. PubMed ID: 26973907
[TBL] [Abstract][Full Text] [Related]
2. "Fault-line of an earthquake": a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, Eastern North Carolina.
Jilcott Pitts SB; Lea CS; May CL; Stowe C; Hamill DJ; Walker KT; Fitzgerald TL
J Rural Health; 2013; 29(1):78-87. PubMed ID: 23289658
[TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
[TBL] [Abstract][Full Text] [Related]
4. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting.
Allison JE; Feldman R; Tekawa IS
Ann Intern Med; 1990 Mar; 112(5):328-33. PubMed ID: 2407166
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
[TBL] [Abstract][Full Text] [Related]
6. Australian women's cervical cancer screening attendance as a function of screening barriers and facilitators.
Brown RF; Muller TR; Olsen A
Soc Sci Med; 2019 Jan; 220():396-402. PubMed ID: 30529797
[TBL] [Abstract][Full Text] [Related]
7. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
Ndejjo R; Mukama T; Kiguli J; Musoke D
BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
[TBL] [Abstract][Full Text] [Related]
8. A comparison of fecal occult-blood tests for colorectal-cancer screening.
Allison JE; Tekawa IS; Ransom LJ; Adrain AL
N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
[TBL] [Abstract][Full Text] [Related]
9. Environmental and Psychosocial Barriers to and Benefits of Cervical Cancer Screening in Kenya.
Buchanan Lunsford N; Ragan K; Lee Smith J; Saraiya M; Aketch M
Oncologist; 2017 Feb; 22(2):173-181. PubMed ID: 28167567
[TBL] [Abstract][Full Text] [Related]
10. Barriers and facilitators of colorectal cancer screening among East African men in Minnesota: a qualitative investigation.
Nakajima M; Mohamud S; Haji A; Pratt R; al'Absi M
Ethn Health; 2024 Jan; 29(1):112-125. PubMed ID: 37968812
[No Abstract] [Full Text] [Related]
11. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler B; Irwig L; Glasziou P; Kewenter J; Weller D; Silagy C
BMJ; 1998 Aug; 317(7158):559-65. PubMed ID: 9721111
[TBL] [Abstract][Full Text] [Related]
12. Awareness of Stomach and Colorectal Cancer Risk Factors, Symptoms and Time Taken to Seek Medical Help Among Public Attending Primary Care Setting in Muscat Governorate, Oman.
Al-Azri M; Al-Kindi J; Al-Harthi T; Al-Dahri M; Panchatcharam SM; Al-Maniri A
J Cancer Educ; 2019 Jun; 34(3):423-434. PubMed ID: 28782080
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
[TBL] [Abstract][Full Text] [Related]
14. [Performance of the Hemoccult test in the screening of colorectal cancer and adenoma. Results of 5 screening campaigns in Saône-et-Loire].
Tazi MA; Faivre J; Lejeune C; Benhamiche AM; Dassonville F
Gastroenterol Clin Biol; 1999 May; 23(5):475-80. PubMed ID: 10429850
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: A qualitative study of midwives' experience.
Oni HT; Buultjens M; Blandthorn J; Davis D; Abdel-Latif M; Islam MM
Midwifery; 2020 Feb; 81():102595. PubMed ID: 31838337
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening.
Honein-AbouHaidar GN; Kastner M; Vuong V; Perrier L; Daly C; Rabeneck L; Straus S; Baxter NN
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):907-17. PubMed ID: 27197277
[TBL] [Abstract][Full Text] [Related]
17. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the OC Sensor
Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
[TBL] [Abstract][Full Text] [Related]
19. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
Racey CS; Gesink DC
J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
